StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
bluebird bio (BLUE) PT Lowered to $19 at Morgan Stanley
August 11, 2021 8:26 AM
Morgan Stanley analyst Matthew Harrison ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Canaccord Genuity Downgrades bluebird bio (BLUE) to Hold
August 10, 2021 8:49 AM
Goldman Sachs Downgrades bluebird bio (BLUE) to Neutral
August 10, 2021 6:56 AM
bluebird bio (BLUE) PT Lowered to $26 at RBC Capital
August 10, 2021 6:13 AM
Wells Fargo Downgrades bluebird bio (BLUE) to Equal Weight
August 10, 2021 6:08 AM
William Blair Reinstates bluebird bio (BLUE) at Market Perform
August 10, 2021 4:29 AM
bluebird bio (BLUE) PT Lowered to $21 at BMO Capital, Following Earnings, Business Update
August 9, 2021 3:50 PM
bluebird bio (BLUE) PT Lowered to $29 at Mizuho Securities, Following Earnings, Business Update
August 9, 2021 3:32 PM
bluebird bio (BLUE) PT Lowered to $37 at JPMorgan, Following Earnings, Business Update
August 9, 2021 2:33 PM
bluebird bio (BLUE) PT Lowered to $18 at Stifel
August 9, 2021 1:56 PM
SVB Leerink Downgrades bluebird bio (BLUE) to Market Perform, Following Earnings, Business Update
August 9, 2021 12:45 PM
bluebird bio (BLUE) Misses Q2 EPS by 39c
August 9, 2021 7:12 AM
Form 10-Q bluebird bio, Inc. For: Jun 30
August 9, 2021 7:05 AM
Form 8-K bluebird bio, Inc. For: Aug 09
August 9, 2021 7:03 AM
bluebird bio Reports Second Quarter Financial Results and Provides Operational Update
August 9, 2021 7:00 AM
